Drug Molecule | Objectives | Prompts | Validity (%) | Hit Ratio (%) | ||
---|---|---|---|---|---|---|
 |  | GPT-3.5 | Ours | GPT-3.5 | Ours | |
Apixaban | Electron-donating substitution | High HOMO energy | 55 | 73 | 1 | 18 |
Empagliflozin | More hydrophilic | Large polarity | 0 | 15 | 0 | 8 |
Ibrutinib | Higher permeability | High permeability | 19 | 33 | 0 | 2 |
Dapagliflozin | Large aqueous solubility | More soluble | 0 | 35 | 0 | 13 |
Osimertinib | Electron-withdrawing substitution | Low HOMO energy | 30 | 52 | 0 | 39 |
Olaparib | Electron-withdrawing substitution | Low HOMO energy | 34 | 30 | 1 | 2 |
Abemaciclib | More hydrogen bonding interactions | More hydrogen bond acceptors | 20 | 42 | 0 | 21 |
 |  | More hydrogen bond donors | 0 | 45 | 0 | 25 |
Pomalidomide | Electron-withdrawing substitution | Low HOMO energy | 24 | 64 | 11 | 10 |
Tafamidis | More hydrogen bonding interactions | More hydrogen bond acceptors | 46 | 61 | 0 | 13 |
 | More hydrogen bond donors | 10 | 48 | 0 | 5 | |
Lisdexamfetamine | To control the hydrolysis rate | High HOMO energy | 0 | 11 | 0 | 8 |
 | Low HOMO energy | 0 | 19 | 0 | 5 |